66891-86-9

Basic information

• Product Name: Carbamic acid, [4-(chlorocarbonyl)phenyl]methyl-, phenylmethyl ester
• CAS NO: 66891-86-9
• Molecular Formula: C16H14ClNO3
• Molecular Weight: 303.745
• Mol File: 66891-86-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [4-(chlorocarbonyl)phenyl]methyl-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [4-(chlorocarbonyl)phenyl]methyl-, phenylmethyl ester(66891-86-9)
• EPA Substance Registry System: Carbamic acid, [4-(chlorocarbonyl)phenyl]methyl-, phenylmethyl ester(66891-86-9)

Safety Data

• Hazardous Substances Data: 66891-86-9(Hazardous Substances Data)

Upstream product

• 2528-30-5 4-<<(benzyloxy)carbonyl>methylamino>benzoic acid 
• 10541-83-0 N-methyl-p-aminobenzoic acid 
• 501-53-1 benzyl chloroformate 

Downstream Products

• 96846-04-7 (S)-2-[4-(Benzyloxycarbonyl-methyl-amino)-benzoylamino]-4-ureido-butyric acid 
• 112513-44-7 2-Amino-4-[4-(benzyloxycarbonyl-methyl-amino)-benzoylamino]-pentanedioic acid diisopropyl ester 
• 102841-31-6 2-[4-(Benzyloxycarbonyl-methyl-amino)-benzoylamino]-2-difluoromethyl-pentanedioic acid dimethyl ester 
• 79974-17-7 N²-<4-<<(benzyloxy)carbonyl>methylamino>benzoyl>-L-glutamine 2,4,6-trimethylbenzyl ester 
• 96846-05-8 N²-<4-<<(benzyloxy)carbonyl>methylamino>benzoyl>-2-amino-3-<<(methylamino)carbonyl>amino>propanoic acid 
• 511544-85-7 α-tert-butyl N-[4-(N-benzyloxycarbonyl-N-methyl)aminobenzoyl]-L-glutamate 
• 66147-29-3 (S)-2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid 1-methyl ester 
• 67036-48-0 (S)-2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-4-methylcarbamoyl-butyric acid 
• 71074-44-7 (S)-2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-4-dimethylcarbamoyl-butyric acid 
• 79974-05-3 (S)-2-[4-(Benzyloxycarbonyl-methyl-amino)-benzoylamino]-4-methylcarbamoyl-butyric acid benzyl ester 
• 79974-16-6 N-<4-<<(benzyloxy)carbonyl>methylamino>benzoyl>-L-glutamic acid α-methyl γ-benzyl ester 
• 79983-10-1 (S)-2-[4-(Benzyloxycarbonyl-methyl-amino)-benzoylamino]-4-dimethylcarbamoyl-butyric acid benzyl ester 
• 64801-59-8 (S)-2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-4-pentylcarbamoyl-butyric acid 
• 71177-43-0 (S)-4-(Carboxymethyl-carbamoyl)-4-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-butyric acid 

Relevant articles and documents

PRODRUGS ACTIVATED BY REACTIVE OXYGEN SPECIES FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES AND CANCER

Prodrugs activated predominantly or exclusively in inflammatory tissue, more particularly prodrugs of methotrexate and derivatives thereof, which are selectively activated by Reactive Oxygen Species (ROS) in inflammatory tissues associated with cancer and inflammatory diseases, as well as method for preparing said prodrugs.

Helical structures of N-alkylated poly(p-benzarnide)s

Poly(p-benzamide)s 1 bearing a chiral side chain on the nitrogen atom were synthesized by chain-growth polycondensation methodology. The polyamides exhibited well-defined molecular weights with narrow polydispersities. Solutions of the polyamides in sever

Syntheses of α- and γ-substituted amides, peptides, and esters of methotrexate and their evaluation as inhibitors of folate metabolism

-